Omid Seidizadeh/LinkedIn
Aug 19, 2025, 17:36
Omid Seidizadeh: Effect of Some Polymorphic Variants on the Platelet-Dependent VWF Activity Assays
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared an LinkedIn:
”We examined the effect of the VWF p.D1472H variant on platelet-dependent VWF activity using four commercially available assays: VWF:GPIbR LIA, VWF:GPIbR CLIA, VWF:RCo automated, and VWF:GPIbM LIA.”
Read the full article here.
Article: Effect of the Polymorphic Variant p.D1472H on the Platelet-Dependent VWF Activity Assays
Authors: Omid Seidizadeh, Lismaira Pati, Luciano Baronciani, Paola Colpani, Giovanna Cozzi, Maria Teresa Pagliari, Cristina Novembrino, Andrea Cairo, Emanuela Pappalardo, Flora Peyvandi
Stay updated on all science in the bleeding disorders’ field with Hemostasis Today.
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Rainer Kaiser: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease
-
Mar 6, 2026, 16:17Paul McKenzie: The Value of Gene Therapy in Bleeding Disorders
-
Mar 6, 2026, 16:15Basma El Homasany: The ‘Little Brain’ of the Heart and Its Role in Health
-
Mar 6, 2026, 16:14Jamal Rana: Family History and Polygenic Risk for Coronary Heart Disease
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis